ZNTL Stock Ownership Activity
ZENTALIS PHARMACEUTICALS INC 13F holders
No value investing guru has made any change to the ZENTALIS PHARMACEUTICALS INC (ZNTL) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying ZNTL now?
According to the latest SEC filing(s) ZENTALIS PHARMACEUTICALS INC (ZNTL) has not been purchased by any super investor.
To see more about who is investing in ZENTALIS PHARMACEUTICALS INC (ZNTL), please go to the ZNTL ownership page.
2022 Q3
(1 result)
Current price: $3.23
88.51%
Reported price*: $28.10
2022 Q1
(1 result)
Current price: $3.23
93.00%
Reported price*: $46.14
2021 Q3
(1 result)
Current price: $3.23
95.15%
Reported price*: $66.64
2021 Q1
(1 result)
Current price: $3.23
92.56%
Reported price*: $43.39
2020 Q4
(1 result)
Current price: $3.23
93.78%
Reported price*: $51.94
2020 Q2
(1 result)
Current price: $3.23
93.27%
Reported price*: $48.02
6 of 6
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.